Skip to content

DAPI Antifade ES

by Cytocell Limited 2 variants

Ref CE-DES 500L

DAPI Antifade ES (CE-DES 500L) is an in vitro diagnostic device (EU IVDR Class A; EMDN category DNA in situ hybridisation reagents) made by Cytocell, Ltd., registered in EUDAMED on 25 May 2022 (Basic UDI-DI 50558449DESWT), active as of 24 Oct 2026.

Active European Union

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number50558449DESWT Basic UDI-DI Date25 May 2022RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Model / reference
CE-DES 500L
Primary DI / UDI-DI
05055844935037, 05055844907300
Basic UDI-DI
50558449DESWT
EMDN code
W01030703 DNA in situ hybridisation reagents
Device class
Class A
EU registration type
Standard device
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
GB-MF-000016893
Authorised representative
Sysmex Europe SE DE-AR-000022333

Similar devices in this category

Other devices filed under DNA IN SITU HYBRIDISATION REAGENTS.

Other devices from Cytocell, Ltd.

See all devices from Cytocell, Ltd. →

Properties

  • Reagent
  • Professional testing
Other properties (11, all answered No)